TREM2 and early-onset autosomal dominant Alzheimer disease: This CD33 isoform counteracts the inhibitory effect of CD33 on TREM2 in microglia and would ultimately reduce amyloid deposition and thus exert a moderate protective effect on Alzheimer’s disease and likely SVID susceptibility46.